Related Experiment Videos
Bell's palsy: an immune complex disease
A Larsson1, L Jonsson, J Sjöquist
1Department of Medical and Physiological Chemistry, Uppsala University, Sweden.
Insights
Bell's palsy patients showed decreased C4 immune complexes, but their serum could still activate C4. This suggests rapid in vivo modification, not a C4 activation defect, in Bell's palsy immune complex formation.
Area of Science:
- Immunology
- Neurology
Background:
- Previous studies indicated elevated C1q- and C3-containing immune complexes in Bell's palsy patients compared to healthy individuals.
- Circulating immune complexes play a role in various autoimmune and inflammatory conditions.
Purpose of the Study:
- To investigate the levels and behavior of C4-containing circulating immune complexes in patients with Bell's palsy.
- To determine if decreased C4 levels are due to impaired activation or other factors.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to quantify C4-containing immune complexes in the serum of 48 Bell's palsy patients.
- Serum ability to activate and bind C4 to a model immune complex was assessed.
Main Results:
- Serum levels of C4-containing immune complexes were found to be slightly decreased in Bell's palsy patients.
- Patients' sera exhibited an increased ability to activate and bind C4 to a model immune complex.
- The findings suggest rapid in vivo modification of C4 within immune complexes or reduced C4 binding, rather than a defect in C4 activation.
Conclusions:
- The low levels of C4-containing immune complexes in Bell's palsy are likely due to post-binding modification or reduced binding efficiency.
- Assays detecting C1q- and C3-containing immune complexes are recommended for serum analysis in Bell's palsy.
- Further research into the in vivo fate of C4 in immune complexes is warranted.
Abstract:
Serum levels of C4-containing circulating immune complexes in 48 patients with Bell's palsy were studied by an enzyme-linked immunosorbent assay (ELISA) using chicken antibodies. We have previously reported elevated levels of C1q- and C3-containing immune complexes when compared to the serum of 42 healthy persons. We now found the levels of C4-containing immune complexes in these sera to be slightly decreased, but these patients' sera had a slightly increased ability to activate and bind C4 to a model immune complex. The results indicate that the fairly low levels of C4-containing immune complexes were not due to a defect in C4 activation but point to a rapid modification of C4 in the immune complex in vivo or low binding of C4 to the immune complexes. This study also shows that it is preferable to use assays that detect C1q- and C3-containing immune complexes when analyzing sera from patients with Bell's palsy.